CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice
Cancer: The Major Medical Challenge in Europe Today (Cancer Cures Made in Austria)
Regulatory & Marketplace v5i2

Cancer: The Major Medical Challenge in Europe Today (Cancer Cures Made in Austria)

Austria is at the forefront in the fight against cancer in Europe, and plays a leading part in the worldwide campaign, with several pioneering initiatives. Be it ...
Continue Reading →
Some Practical Implications of the UP and the UPC for the Pharmaceutical Sector
Editorial Archive

Some Practical Implications of the UP and the UPC for the Pharmaceutical Sector

On 19 February 2013, 24 EU member states signed a supra-national agreement which is intended to bring into being a new court called the Uniform Patent Court. Th...
Continue Reading →
Grabbing Hold of the Bar of Success in Drug Development
Editorial Archive

Grabbing Hold of the Bar of Success in Drug Development

Globalisation and other recent developments such as stricter quality control criteria, evolving technologies, and the increasing stringency of regulatory stand...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026